Suppr超能文献

严重低钠血症中钠过度纠正的风险及去氨加压素的效用:一项大型回顾性研究。

The risk of sodium overcorrections in severe hyponatremia and the utility of desmopressin: a large retrospective study.

作者信息

Lamarche Florence, Ammann Hélène, Dallaire Gabriel, Deslauriers Louis, Troyanov Stéphan

机构信息

Department of Medicine, Nephrology Service, Hôpital du Sacré-Coeur de Montréal, University of Montréal, Montréal, Quebec, Canada.

Department of Medicine, Biochemistry Service, Hôpital du Sacré-Coeur de Montréal, University of Montréal, Montréal, Quebec, Canada.

出版信息

Clin Kidney J. 2024 Nov 29;18(2):sfae386. doi: 10.1093/ckj/sfae386. eCollection 2025 Feb.

Abstract

BACKGROUND

The suggested narrow rate of serum sodium (sNa) correction in hyponatremia can be difficult to respect, leading to overcorrections. Our ability to anticipate the rapidity of correction according to the mechanism of hyponatremia is uncertain. While desmopressin is often used to pause a rapid rise in sNa, its dose-related effect is also not well described. We studied the rate of hyponatremia overcorrections, its prediction and the utility of desmopressin in its management.

METHODS

We retrospectively reviewed all cases of severe hyponatremia (sNa <120 mmol/L) in a large university hospital that occurred over 10 years. We assessed investigations, causes and treatments. We compared all sNa separated by at least 8 h and calculated correction rates. Significant overcorrection rates were defined by any rise of sNa >9 mmol/L per day sustained over at least 24 h.

RESULTS

After exclusions, we found 355 episodes of severe hyponatremia. Low, appropriate and inappropriate antidiuretic hormone (ADH)-defined mechanisms accounted for 17%, 24% and 29% of etiologies, respectively, with the remaining 25% secondary to diuretics and 5% of uncertain causes. First urinary sodium and osmolality were consistent with the final diagnosis in 73%. Significant overcorrections were seen in 45% and were frequent in the setting of low ADH. Desmopressin was given in 82 episodes, more often as a rescue than a preventive measure, with the subsequent sNa dropping by ≥5 mmol/L by 12 h in eight instances. The dose of desmopressin (≥2 µg versus 1 µg) and a higher volume of intravenous free-water coadministration resulted in a clinically meaningful greater reduction in sNa in the following 12 h.

CONCLUSIONS

Overcorrections in severe hyponatremia are common, mainly when ADH is low. Initial urinary measurements anticipate this risk. Desmopressin effectively halted the rate of correction in a dose-dependent manner. Caution should be given when coadministrating water, which can significantly lower the sNa.

摘要

背景

低钠血症时建议的血清钠(sNa)纠正速度可能难以遵守,从而导致纠正过度。我们根据低钠血症的机制预测纠正速度的能力尚不确定。虽然去氨加压素常用于暂停sNa的快速上升,但其剂量相关效应也未得到充分描述。我们研究了低钠血症纠正过度的发生率、预测方法以及去氨加压素在其治疗中的作用。

方法

我们回顾性分析了一所大型大学医院10年间发生的所有严重低钠血症(sNa<120 mmol/L)病例。我们评估了检查、病因和治疗方法。我们比较了至少间隔8小时的所有sNa值,并计算了纠正率。显著纠正过度率定义为sNa每天升高>9 mmol/L并持续至少24小时。

结果

排除后,我们发现355例严重低钠血症发作。抗利尿激素(ADH)水平低、正常和异常所定义的机制分别占病因的17%、24%和29%,其余25%继发于利尿剂,5%病因不明。首次尿钠和渗透压与最终诊断相符的比例为73%。45%的病例出现显著纠正过度,在ADH水平低的情况下很常见。82例患者使用了去氨加压素,更多是作为一种补救措施而非预防措施,8例患者在使用后12小时内sNa下降≥5 mmol/L。去氨加压素剂量(≥2 µg与1 µg相比)以及更高剂量的静脉输注游离水共同给药导致随后12小时内sNa有临床意义的更大幅度下降。

结论

严重低钠血症的纠正过度很常见,主要发生在ADH水平低时。初始尿测量可预测这种风险。去氨加压素以剂量依赖的方式有效减缓了纠正速度。联合使用水时应谨慎,因为这可能会显著降低sNa。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366d/11997796/8a4255e5c8c6/sfae386fig1g.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验